1. Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis.
- Author
-
Preiss, David, Tikkanen, Matti T., Welsh, Paul, Ford, Ian, Lovato, Laura C., Elam, Marshall B., LaRosa, John C., DeMicco, David A., Colhoun, Helen M., Goldenberg, Han, Murphy, Michael J., MacDonald, Thomas M., Pedersen, Terie R., Keech, Anthony C., Ridker, Paul M., Kjekshus, John, Sattar, Naveed, and McMurray, John J. V.
- Subjects
- *
PANCREATITIS treatment , *LIPIDS , *STATINS (Cardiovascular agents) , *EZETIMIBE , *HYPERTRIGLYCERIDEMIA , *META-analysis , *CLINICAL trials , *CHARTS, diagrams, etc. , *CHRONIC diseases , *ACUTE diseases , *THERAPEUTICS - Abstract
The article focuses on a study related to the treatment of pancreatitis with the help of lipid modification. Meta analysis method was used in the collection of several data related to randomize clinical trials. It mentions that treatment of pancreatitis that statin and ezetimibe with placebo were effective in controlling the disease and hypertriglyceridemia was reported to be the common cause of pancreatitis. A flowchart and a table are also presented related to several lipid modification trials. The author states that they were not able to differentiate pancreatitis in chronic and acute cases.
- Published
- 2012
- Full Text
- View/download PDF